Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for Cardiac-induced Edema in CHF
NCT00544869Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Oct 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tolvaptan in heart failure (HF), edema secondary to heart failure, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Oct 2007; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)edema secondary to heart failure
Beyond the preview
Go deeper on NCT00544869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544869.